| 1 | [SID49673088] | Active | Potency | 0.259 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Primary screen confirmation [AID2787, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | Potency | 0.259 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Primary screen confirmation | | AID | 2787 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 2 | [SID49673088] | Active | Potency | 0.73 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen confirmation [AID2795, Type: confirmatory] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | Potency | 0.73 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen confirmation | | AID | 2795 | | BioAssay type | confirmatory | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 3 | [SID49673088] | Active | Potency | 0.73 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen confirmation [AID2795, Type: confirmatory] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | Potency | 0.73 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen confirmation | | AID | 2795 | | BioAssay type | confirmatory | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 4 | [SID49673088] | Active | AC50 | 2.062 | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_Dose_CherryPick_Activity [AID493248, Type: confirmatory] | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | AC50 | 2.062 [uM] | | BioAssay | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_Dose_CherryPick_Activity | | AID | 493248 | | BioAssay type | confirmatory | | Target | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] | | PubMed | | | Data Table |  |
|
| 5 | [SID49673088] | Active | Potency | 3.2944 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | Potency | 3.2944 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID49673088] | Active | Potency | 5.8048 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | Potency | 5.8048 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID49673088] | Active | Potency | 5.8048 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | Potency | 5.8048 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID49673088] | Active | Potency | 5.8048 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | Potency | 5.8048 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 9 | [SID49673088] | Active | Potency | 6.3096 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 10 | [SID49673088] | Active | Potency | 6.5131 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | Potency | 6.5131 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 11 | [SID49673088] | Active | Potency | 6.5131 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | Potency | 6.5131 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 12 | [SID49673088] | Active | Potency | 6.5131 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | Potency | 6.5131 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 13 | [SID49673088] | Active | Potency | 6.7456 | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | Potency | 6.7456 [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 14 | [SID49673088] | Active | Potency | 11.2202 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 15 | [SID49673088] | Active | Potency | 12.5893 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID49673088] | Active | IC50 | 14.289 | Discovery of Small Molecule Probes for H1N1 Influenza NS1A [AID504329, Type: confirmatory] | nonstructural protein 1 [Influenza A virus (A/California/07/2009(H1N1))] [gi:227977143] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | IC50 | 14.289 [uM] | | BioAssay | Discovery of Small Molecule Probes for H1N1 Influenza NS1A | | AID | 504329 | | BioAssay type | confirmatory | | Target | nonstructural protein 1 [Influenza A virus (A/California/07/2009(H1N1))] [gi:227977143] | | PubMed | | | Data Table |  |
|
| 17 | [SID49673088] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 18 | [SID49673088] | Active | Potency | 16.3535 | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504467, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | Potency | 16.3535 [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504467 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 19 | [SID49673088] | Active | AC50 | 20.17 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis [AID449756, Type: confirmatory] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | AC50 | 20.17 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis | | AID | 449756 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID49673088] | Active | Potency | 20.5962 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID49673088] | Active | Potency | 22.3872 | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide [AID1768, Type: confirmatory] | MEN1 gene product [Homo sapiens] [gi:18860839] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide | | AID | 1768 | | BioAssay type | confirmatory | | Target | MEN1 gene product [Homo sapiens] [gi:18860839] | | PubMed | | | Data Table |  |
|
| 22 | [SID49673088] | Active | IC50 | 100 | Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition [AID588689, Type: confirmatory] | Chain A, Crystal Structure Of Dengue-2 Virus Methyltransferase Complexed With S-Adenosyl-L-Homocyste [gi:219689243] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | IC50 | 100 [uM] | | BioAssay | Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition | | AID | 588689 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Dengue-2 Virus Methyltransferase Complexed With S-Adenosyl-L-Homocyste [gi:219689243] | | PubMed | | | Data Table |  |
|
| 23 | [SID49673088] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the HTRA serine peptidase 1 (HTRA1) [AID540248, Type: other] | HTRA1 protein [gi:121945198] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the HTRA serine peptidase 1 (HTRA1) | | AID | 540248 | | BioAssay type | other | | Target | HTRA1 protein [gi:121945198] | | PubMed | | | Data Table |  |
|
| 24 | [SID49673088] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) [AID504803, Type: screening] | HTRA1 protein [gi:121945198] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) | | AID | 504803 | | BioAssay type | screening | | Target | HTRA1 protein [gi:121945198] | | PubMed | | | Data Table |  |
|
| 25 | [SID49673088] | Active | | | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3) [AID1800, Type: screening] | NS3 [Hepatitis C virus] [gi:125541954] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3) | | AID | 1800 | | BioAssay type | screening | | Target | NS3 [Hepatitis C virus] [gi:125541954] | | PubMed | | | Data Table |  |
|
| 26 | [SID49673088] | Active | | | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS [AID485317, Type: screening] | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS | | AID | 485317 | | BioAssay type | screening | | Target | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] | | PubMed | | | Data Table |  |
|
| 27 | [SID49673088] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 28 | [SID49673088] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 29 | [SID49673088] | Active | | | uHTS Fluorescent assay for identification of inhibitors of Apaf-1 [AID489030, Type: screening] | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | uHTS Fluorescent assay for identification of inhibitors of Apaf-1 | | AID | 489030 | | BioAssay type | screening | | Target | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] | | PubMed | | | Data Table |  |
|
| 30 | [SID49673088] | Active | | | Counter screen in the myeloid differentiation screening campaign for compound fluorescence with Cherry Pick01 [AID651707, Type: other] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Counter screen in the myeloid differentiation screening campaign for compound fluorescence with Cherry Pick01 | | AID | 651707 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID49673088] | Active | | | uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay [AID504690, Type: screening] | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay | | AID | 504690 | | BioAssay type | screening | | Target | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] | | PubMed | | | Data Table |  |
|
| 32 | [SID49673088] | Active | | | Counter screen for compounds that modulate transient receptor potential cation channel C6 (TRPC6) [AID488924, Type: screening] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Counter screen for compounds that modulate transient receptor potential cation channel C6 (TRPC6) | | AID | 488924 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID49673088] | Active | | | Counter screen for identification of compounds that activate the regulator of G-protein signaling 4 (RGS4): Non-induced cells with the primary screen assay [AID602283, Type: screening] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Counter screen for identification of compounds that activate the regulator of G-protein signaling 4 (RGS4): Non-induced cells with the primary screen assay | | AID | 602283 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID49673088] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. [AID435005, Type: screening] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. | | AID | 435005 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID49673088] | Active | | | Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity [AID651704, Type: screening] | MLLT3 gene product [Homo sapiens] [gi:156104889] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651704 | | BioAssay type | screening | | Target | MLLT3 gene product [Homo sapiens] [gi:156104889] | | PubMed | | | Data Table |  |
|
| 36 | [SID49673088] | Active | | | Validation assay for identification of compounds that activate the regulator of G-protein signaling 4 (RGS4) [AID602282, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Validation assay for identification of compounds that activate the regulator of G-protein signaling 4 (RGS4) | | AID | 602282 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 37 | [SID49673088] | Active | | | Validation assay for identification of compounds that activate the regulator of G-protein signaling 4 (RGS4) [AID602282, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Validation assay for identification of compounds that activate the regulator of G-protein signaling 4 (RGS4) | | AID | 602282 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 38 | [SID49673088] | Active | | | Validation assay for identification of compounds that activate the regulator of G-protein signaling 4 (RGS4) [AID602282, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Validation assay for identification of compounds that activate the regulator of G-protein signaling 4 (RGS4) | | AID | 602282 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 39 | [SID49673088] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) [AID463111, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) | | AID | 463111 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 40 | [SID49673088] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) [AID463111, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) | | AID | 463111 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 41 | [SID49673088] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) [AID463111, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) | | AID | 463111 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 42 | [SID49673088] | Active | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 1974 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 43 | [SID49673088] | Active | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 1974 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 44 | [SID49673088] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 45 | [SID49673088] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 46 | [SID49673088] | Active | | | High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6) [AID2553, Type: screening] | short transient receptor potential channel 6 [Mus musculus] [gi:160333370] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6) | | AID | 2553 | | BioAssay type | screening | | Target | short transient receptor potential channel 6 [Mus musculus] [gi:160333370] | | PubMed | | | Data Table |  |
|
| 47 | [SID49673088] | Active | | | Specificity screen against TRPC4 for compounds that modulate transient receptor potential cation channel C6 (TRPC6) [AID488927, Type: screening] | alternatively spliced Trp4 [Mus musculus] [gi:2935630] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Specificity screen against TRPC4 for compounds that modulate transient receptor potential cation channel C6 (TRPC6) | | AID | 488927 | | BioAssay type | screening | | Target | alternatively spliced Trp4 [Mus musculus] [gi:2935630] | | PubMed | | | Data Table |  |
|
| 48 | [SID49673088] | Active | | | Second specificity screen against TRPC4 for compounds that modulate transient receptor potential cation channel C6 (TRPC6) [AID488928, Type: screening] | alternatively spliced Trp4 [Mus musculus] [gi:2935630] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Second specificity screen against TRPC4 for compounds that modulate transient receptor potential cation channel C6 (TRPC6) | | AID | 488928 | | BioAssay type | screening | | Target | alternatively spliced Trp4 [Mus musculus] [gi:2935630] | | PubMed | | | Data Table |  |
|
| 49 | [SID49673088] | Active | | | Confirmatory screen for identification of compounds that inhibit transient receptor potential cation channel C6 (TRPC6) [AID488960, Type: screening] | short transient receptor potential channel 6 [Mus musculus] [gi:160333370] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Confirmatory screen for identification of compounds that inhibit transient receptor potential cation channel C6 (TRPC6) | | AID | 488960 | | BioAssay type | screening | | Target | short transient receptor potential channel 6 [Mus musculus] [gi:160333370] | | PubMed | | | Data Table |  |
|
| 50 | [SID49673088] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1). [AID1950, Type: screening] | EBNA-1 protein [Human herpesvirus 4] [gi:23893623] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49673088 | | CID | 740387 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1). | | AID | 1950 | | BioAssay type | screening | | Target | EBNA-1 protein [Human herpesvirus 4] [gi:23893623] | | PubMed | | | Data Table |  |
|